FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386067264> ?p ?o ?g. }

• W4386067264 abstract "Both AIDS-defining and non-AIDS-defining cancers (ADC/NADC) predispose people living with HIV (PLHIV) to critical illnesses. The objective of this multicentre study was to investigate the prognostic impact of ADC and NADC in PLHIV admitted to the intensive care unit (ICU).All PLHIV admitted over the 2015-2020 period in 12 university-affiliated ICUs in France were included in the study cohort. The effect of ADC and NADC on in-hospital mortality (primary study endpoint) was measured through logistic regression with augmented backward elimination of potential independent variables. The association between ADC/NADC and treatment limitation decision (TLD) during the ICU stay (secondary study endpoint) was analysed. One-year mortality in patients discharged alive from the index hospital admission (exploratory study endpoint) was compared between those with ADC, NADC or no cancer.Amongst the 939 included PLHIV (median age, 52 [43-59] years; combination antiretroviral therapy, 74.4%), 97 (10.3%) and 106 (11.3%) presented with an active NADC (mostly lung and intestinal neoplasms) and an active ADC (predominantly AIDS-defining non-Hodgkin lymphoma), respectively. Inaugural admissions were common. Bacterial sepsis and non-infectious neoplasm-related complications accounted for most of admissions in these subgroups. Hospital mortality was 12.4% in patients without cancer, 30.2% in ADC patients and 45.4% in NADC patients (P < 0.0001). NADC (adjusted odds ratio [aOR], 7.00; 95% confidence interval [CI], 4.07-12.05) and ADC (aOR, 3.11; 95% CI 1.76-5.51) were independently associated with in-hospital death after adjustment on severity and frailty markers. The prevalence of TLD was 8.0% in patients without cancer, 17.9% in ADC patients and 33.0% in NADC patients (P < 0.0001)-organ failures and non-neoplastic comorbidities were less often considered in patients with cancer. One-year mortality in survivors of the index hospital admission was 7.8% in patients without cancer, 17.0% in ADC patients and 33.3% in NADC patients (P < 0.0001).NADC and ADC are equally prevalent, stand as a leading argument for TLD, and strongly predict in-hospital death in the current population of PLHIV requiring ICU admission." @default.
• W4386067264 created "2023-08-23" @default.
• W4386067264 creator A5000822953 @default.
• W4386067264 creator A5002840696 @default.
• W4386067264 creator A5010666040 @default.
• W4386067264 creator A5028389613 @default.
• W4386067264 creator A5045779109 @default.
• W4386067264 creator A5057058749 @default.
• W4386067264 creator A5057479113 @default.
• W4386067264 creator A5066459531 @default.
• W4386067264 creator A5068053810 @default.
• W4386067264 creator A5071283928 @default.
• W4386067264 creator A5076578951 @default.
• W4386067264 creator A5083558953 @default.
• W4386067264 creator A5086344364 @default.
• W4386067264 creator A5092674764 @default.
• W4386067264 date "2023-08-22" @default.
• W4386067264 modified "2023-10-17" @default.
• W4386067264 title "Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study" @default.
• W4386067264 cites W1833052174 @default.
• W4386067264 cites W1968850993 @default.
• W4386067264 cites W1972922117 @default.
• W4386067264 cites W1973681382 @default.
• W4386067264 cites W1981372508 @default.
• W4386067264 cites W1983476230 @default.
• W4386067264 cites W2031869772 @default.
• W4386067264 cites W2037719985 @default.
• W4386067264 cites W2074204947 @default.
• W4386067264 cites W2074624340 @default.
• W4386067264 cites W2090875016 @default.
• W4386067264 cites W2103115327 @default.
• W4386067264 cites W2122597715 @default.
• W4386067264 cites W2124892937 @default.
• W4386067264 cites W2125450552 @default.
• W4386067264 cites W2134923759 @default.
• W4386067264 cites W2148270065 @default.
• W4386067264 cites W2150469511 @default.
• W4386067264 cites W2159473962 @default.
• W4386067264 cites W2233074370 @default.
• W4386067264 cites W2255468460 @default.
• W4386067264 cites W2562813092 @default.
• W4386067264 cites W2599076725 @default.
• W4386067264 cites W2742294946 @default.
• W4386067264 cites W2782176193 @default.
• W4386067264 cites W2783357941 @default.
• W4386067264 cites W2800751318 @default.
• W4386067264 cites W2884465301 @default.
• W4386067264 cites W2887697924 @default.
• W4386067264 cites W2951316852 @default.
• W4386067264 cites W2965623006 @default.
• W4386067264 cites W2967089600 @default.
• W4386067264 cites W2977332845 @default.
• W4386067264 cites W2977557935 @default.
• W4386067264 cites W2994275110 @default.
• W4386067264 cites W3003414838 @default.
• W4386067264 cites W3044752890 @default.
• W4386067264 cites W3112670909 @default.
• W4386067264 cites W3130066512 @default.
• W4386067264 cites W3158874732 @default.
• W4386067264 cites W3165064377 @default.
• W4386067264 cites W3197423430 @default.
• W4386067264 cites W4225331940 @default.
• W4386067264 cites W4280555989 @default.
• W4386067264 cites W4292229870 @default.
• W4386067264 cites W4297231278 @default.
• W4386067264 cites W4304845744 @default.
• W4386067264 cites W4310567938 @default.
• W4386067264 cites W4320891341 @default.
• W4386067264 cites W4324045706 @default.
• W4386067264 doi "https://doi.org/10.1186/s13613-023-01171-4" @default.
• W4386067264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37608140" @default.
• W4386067264 hasPublicationYear "2023" @default.
• W4386067264 type Work @default.
• W4386067264 citedByCount "0" @default.
• W4386067264 crossrefType "journal-article" @default.
• W4386067264 hasAuthorship W4386067264A5000822953 @default.
• W4386067264 hasAuthorship W4386067264A5002840696 @default.
• W4386067264 hasAuthorship W4386067264A5010666040 @default.
• W4386067264 hasAuthorship W4386067264A5028389613 @default.
• W4386067264 hasAuthorship W4386067264A5045779109 @default.
• W4386067264 hasAuthorship W4386067264A5057058749 @default.
• W4386067264 hasAuthorship W4386067264A5057479113 @default.
• W4386067264 hasAuthorship W4386067264A5066459531 @default.
• W4386067264 hasAuthorship W4386067264A5068053810 @default.
• W4386067264 hasAuthorship W4386067264A5071283928 @default.
• W4386067264 hasAuthorship W4386067264A5076578951 @default.
• W4386067264 hasAuthorship W4386067264A5083558953 @default.
• W4386067264 hasAuthorship W4386067264A5086344364 @default.
• W4386067264 hasAuthorship W4386067264A5092674764 @default.
• W4386067264 hasBestOaLocation W43860672641 @default.
• W4386067264 hasConcept C121608353 @default.
• W4386067264 hasConcept C126322002 @default.
• W4386067264 hasConcept C156957248 @default.
• W4386067264 hasConcept C201903717 @default.
• W4386067264 hasConcept C203092338 @default.
• W4386067264 hasConcept C2776376669 @default.
• W4386067264 hasConcept C44249647 @default.
• W4386067264 hasConcept C535046627 @default.
• W4386067264 hasConcept C71924100 @default.
• W4386067264 hasConcept C72563966 @default.

• next